Search All News
Amyloid sparks an alliance between two proteins in the brain that can potentially explain up to half of the gene changes that occur in Alzheimer’s.
Multiple sclerosis (MS) usually begins between the ages of 20 and 40 and is the most common disabling neurological disorder of young adults.
Columbia researchers have discovered how a genetic defect leads to spinal muscular atrophy, a finding that could lead to a new therapy for a disease that affects 1 in 6,000 children.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
- May 14, 1998
- March 13, 1998
- February 18, 1998
- October 23, 1997
- October 15, 1997
- October 7, 1997